Cargando…
Molecularly targeted treatment of recurrent anaplastic astrocytoma – a case report
High‐grade astrocytomas are malignant and aggressive, with limited treatment options. Treatment is geared not only toward increasing patient’s overall survival but also in delaying or preventing neurological disability, a cause of significant morbidity. Increasingly, targeted and customized treatmen...
Autores principales: | Yalamanchi, Ashna, Gill, Jaya Mini, Truong, Judy, Nguyen, Minhdan, Carrillo, Jose, Wagle, Naveed, Sharma, Akanksha, Kesari, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419407/ https://www.ncbi.nlm.nih.gov/pubmed/34328281 http://dx.doi.org/10.1002/acn3.51430 |
Ejemplares similares
-
Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma
por: Sarica, Feyzi Birol, et al.
Publicado: (2012) -
Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013) -
The genetic landscape of anaplastic astrocytoma
por: Killela, Patrick J., et al.
Publicado: (2013) -
Activity of pemetrexed in pre-clinical chordoma models and humans
por: Kesari, Santosh, et al.
Publicado: (2023) -
A rare, pediatric, fourth-ventricular, anaplastic astrocytoma
por: Hiep, Dang Vinh, et al.
Publicado: (2021)